Quanta, Inc. (QNTA)
| Market Cap | 1.46M |
| Revenue (ttm) | 549,174 |
| Net Income (ttm) | -8,253 |
| Shares Out | 429.18M |
| EPS (ttm) | -0.04 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 195,551 |
| Open | 0.0033 |
| Previous Close | 0.0036 |
| Day's Range | 0.0033 - 0.0036 |
| 52-Week Range | 0.0029 - 0.0895 |
| Beta | 1.06 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About QNTA
Quanta, Inc., an applied science company, provides pharmaceutical, nutraceutical, topical relief, and cosmetic products in the United States. The company offers contract research services, including research, development, and production of pharmaceutical-grade products, as well as clinical evidence-based nutraceuticals utilizing patented polarization technology. It also manufactures and distributes consumer wellness products in areas of pain relief, beauty, and general wellness. The company was founded in 2016 and is headquartered in Burbank, C...
News
Medolife Rx Schedules Conference Call with Investment Community to Discuss New Updates and Answer Questions
BURBANK, CA, May 04, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated biotech company with R&D, manufacturing, and consumer product distribution, which is ...
Medolife Rx Announces Changes to Management and Improvements to AELIA's Marketing Efforts
BURBANK, CA, Feb. 07, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Medolife Rx, Inc. ("Medolife"), a global integrated biopharmaceutical company with R&D, manufacturing, and consumer product distributi...
Medolife Rx Submits Final Clinical Trial Data for Escozine Approval as a COVID-19 Treatment in The Dominican Republic
BURBANK, Calif., Jan. 19, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Medolife Rx, Inc. ("Medolife"), a global integrated biopharmaceutical company with R&D, manufacturing, and consumer product distrib...
Medolife Rx Announces Results of Comparative Study of Its Flagship CBD-based Muscle Rub and Competitor Products
BURBANK, Calif., Dec. 02, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated biopharmaceutical company with R&D, manufacturing, and consumer product distribu...
Medolife Rx Schedules Conference Call with Investment Community To Discuss Third Quarter 2021 Financial and Operation...
BURBANK, Calif., Nov. 19, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, ...
Medolife Rx Announces Upcoming Release of New Aelia Commercials Featuring Tony Hawk
BURBANK, Calif., Nov. 11, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, ...
Medolife Rx Announces Uplisting to OTCQB Venture Market
BURBANK, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, ...
Medolife Rx Announces that the Government of the Dominican Republic is Willing to Include Escozine into its COVID-19 ...
BURBANK, Calif., Oct. 14, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Medolife Rx, Inc. ("Medolife"), a global integrated biopharmaceutical company with R&D, manufacturing, and consumer product distrib...
Medolife Rx Reports 257% Increase in Efficacy of Ibuprofen Through Proprietary Polarization Method, Looks to Expand I...
BURBANK, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated biopharmaceutical company with R&D, manufacturing, and consumer product distribu...
Medolife Rx Initiates Comparative Study of Its Flagship CBD-based Muscle Rub and Competitor
BURBANK, Calif., Oct. 06, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated biopharmaceutical company with R&D, manufacturing, and consumer product distribu...
Medolife Rx Files Bi-Annual Report With Ministry of Environment in the Dominican Republic, Details Reservation Expans...
BURBANK, Calif., Sept. 29, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution,...
Medolife Rx Launches Ad Campaign With Tony Hawk, Sees Immediate Positive Results
BURBANK, CA, Sept. 23, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, w...
Medolife Rx Clarifies April 13, 2021 Press Release
BURBANK, Calif., Sept. 21, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Medolife Rx, Inc. ("Medolife" or the “Company”), a global integrated bioceutical company with R&D, manufacturing, and consumer pro...
Medolife Rx Recaps Successful Attendance at Tony Hawk Event; Saw Significant Product Exposure
BURBANK, CA, Sept. 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, w...
Medolife Rx Reports Second Quarter 2021 Financial and Operational Results, Schedules Conference Call With Investment ...
BURBANK, Calif., Aug. 23, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution,...
Medolife Rx Schedules Investor Webcast for Tuesday, July 27, 2021
BURBANK, CA, July 21, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, whi...
Medolife Rx Announces Donation of Escozine to Heath Clinic in Dominican Republic for Use on Growing COVID-19 Positive...
BURBANK, Calif., July 14, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated biopharmaceutical company with R&D, manufacturing, and consumer product distribu...
Medolife Rx Clinical Observations Demonstrates Effectiveness of Escozine in Complementary Use with COVID-19 Vaccines
BURBANK, Calif., July 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated biopharmaceutical company with R&D, manufacturing, and consumer product distribu...
Medolife Rx Announces Successful Stability Results on Escozine Conjugated With Radioactive Iodine
BURBANK, Calif., July 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated biopharmaceutical company with R&D, manufacturing, and consumer product distribu...
Medolife Rx Enters Partnership Agreement with Leading International Distributor, Brings Products to Mexico
BURBANK, Calif., June 29, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated biopharmaceutical company with R&D, manufacturing, and consumer product distribu...
FDA Accepts COVID-19 Clinical Study and Advises on Next Steps for Pre-IND Filing by Medolife Rx
BURBANK, Calif., June 23, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated biopharmaceutical company with R&D, manufacturing, and consumer products, which...
Medolife Rx Provides Comment on Business in Lieu of Webcast Scheduled for June 8, 2021
BURBANK, Calif., June 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution,...